Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.
2.

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Andersson T.

Clin Pharmacokinet. 1996 Jul;31(1):9-28. Review. Erratum in: Clin Pharmacokinet 1996 Oct;31(4):274.

PMID:
8827397
3.

Lansoprazole: a comprehensive review.

Zimmermann AE, Katona BG.

Pharmacotherapy. 1997 Mar-Apr;17(2):308-26. Review.

PMID:
9085323
4.

Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.

Gremse DA.

Expert Opin Pharmacother. 2001 Oct;2(10):1663-70. Review.

PMID:
11825309
5.
6.

Lansoprazole: a proton pump inhibitor.

Garnett WR.

Ann Pharmacother. 1996 Dec;30(12):1425-36. Review.

PMID:
8968456
7.

Lansoprazole and omeprazole in the treatment of acid peptic disorders.

Blum RA.

Am J Health Syst Pharm. 1996 Jun 15;53(12):1401-15. Review.

PMID:
8781686
8.
9.

[Lansoprazol ++ : a new proton pump inhibitor].

Baczek J, Laskowiec G.

Pol Merkur Lekarski. 1998 Jun;4(24):339-41. Review. Polish.

PMID:
9771021
10.

Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.

Howden CW.

Am J Health Syst Pharm. 1999 Dec 1;56(23 Suppl 4):S5-11. Review. Erratum in: Am J Health Syst Pharm 2000 Apr 1;57(7):699.

PMID:
10597118
11.

Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Hatlebakk JG, Berstad A.

Clin Pharmacokinet. 1996 Nov;31(5):386-406. Review.

PMID:
9118586
13.

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Welage LS, Berardi RR.

J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. Review.

PMID:
10665250
14.

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.

Fitton A, Wiseman L.

Drugs. 1996 Mar;51(3):460-82. Review. Erratum in: Drugs 1996 Jun;51(6):1074. Drugs 1996 Jul;52(1):92.

PMID:
8882382

Supplemental Content

Support Center